Dear Members,
Your directors have the pleasure in presenting the Thirty-First (31st)
Annual Report of the Company for the year ended March 31, 2026.
FINANCIAL PERFORMANCE
A summary of the Company?s financial performance for the year is
provided below:
(Amount ' in Lakh)
| Particulars |
March 31, 2026 |
March 31, 2025 |
| Operating Profit (Before Interest &
Depreciation) |
6,322.92 |
6,105.37 |
| Less: Finance costs |
2,074.57 |
2,794.79 |
| Profit before Depreciation |
4,248.35 |
3,310.58 |
| Less: Depreciation and amortization expenses |
1,873.00 |
1,839.89 |
| Profit before Exceptional item and tax |
2,375.35 |
1,470.69 |
| Exceptional Item |
262.88 |
- |
| Profit / (Loss) before Tax |
2,112.47 |
1470.69 |
| Current Tax |
855.53 |
362.49 |
| Adjustment of tax related to earlier years |
3.43 |
-3.27 |
| Deferred Tax |
-234.01 |
61.40 |
| Profit after Tax |
1,487.52 |
1,050.07 |
1. REVIEW OF BUSINESS OPERATIONS
Your directors are pleased to present the Financial Report for year
ended March 31, 2026.
The year under review has remained very eventful creating strong growth
base for your Company. Significant events as under:
a) IPO and Listing
Amanta Healthcare Limited launched a fresh issue of 1 crore equity
shares, totaling ^126 crore, and successfully got its equity shares listed & traded on
the National Stock Exchange of India Limited (NSE) and BSE Limited (BSE) with effect from
September 9, 2025.
b) Preference Shares Redemption:
As part of its capital restructuring, the company redeemed preference
shares during this period, aimed at simplifying the capital structure post-IPO.
c) Expansion Projects:
The company is implementing major capital expenditure utilizing IPO
proceeds to set up new manufacturing lines for SteriPort (approx. ^ 90 crore) and Small
Volume Parenterals (SVP) (approx. ^30.13 crore) at its facility in Hariyala, Dist.- Kheda,
Gujarat.
The Steriport project is currently at completion stage and commercial
operations expected by Sept 2026. The SVP line is targeted for completion during Q4 2027.
d) Solar initiative for Cost Optimization:
To improve operational efficiency and reduce energy costs, Amanta
Healthcare Limited has set up a 10.8 MW captive solar power plant. Generation from the
plant has already started from June 2026.
The investment is part of the company?s ESG (Environmental,
Social, and
Governance) initiatives and is specifically intended to optimize
operational costs by reducing electricity expenses.
As far as the operations are concerned, as company is operating at full
capacity the turnover of the company for the year ended 31st March, 2026 has
remained stable. Company has achieved turnover of Rs. 28767.67 lakhs for FY 26 against Rs.
27471 lakhs for FY 25.
Domestic demand for our product is robust. At the same time Company
aims to increase export business significantly creating a strong base for future.
2. CHANGES IN SHARE CAPITAL OF THE COMPANY
Authorized Share Capital
The authorized share capital of the Company remains unchanged at ^.
90,15,00,000 comprising of 8,01,50,000 equity shares of ^10 each and 1,00,00,000
preference shares of Rs. 10 each.
Paid-Up Share Capital
The paid-up share capital of the Company has been increased from
28,82,93,510 comprising of 2,88,29,351 equity shares of =? 10 each to 38,82,93,510
comprising of 3,88,29,351 equity shares of ^ 10 each, pursuant to shares allotted on
account of Initial Public Offering during the year.
Redemption of Preference Shares (RPS)
The Company has redeemed 1,00,00,000 redeemable preference shares of
^10 each, which were issued on 30th March, 2022.
The redemption was carried out on 29th September, 2025 at a
premium of ^11.742 per RPS, out of the distributable profits of the Company, in accordance
with the provisions of Section 55 of the Companies Act, 2013 and the terms of issue
authorized by the Articles of Association.
An amount equal to the nominal value of RPS i.e., ^ 10,00,00,000
(Rupees Ten Crores only), has been transferred to the Capital Redemption Reserve (CRR)
Account from the balance of distributable profits available in the Statement of Profit and
Loss, in accordance with the provisions of the Act.
Initial Public Offering
Amanta Healthcare Limited a leading player in the field of wide variety
of large and small volume preparations in sterile dosage forms, has initiated its Initial
Public Offering (IPO), marking a pivotal development in its over three-decade-long
corporate journey. Incorporated in 1994 and headquartered in Ahmedabad, Amanta Healthcare
Limited has grown into a significant provider of sterile liquid and have geared its
production facility to become a versatile manufacturer.
The IPO comprised of 1,00,00,000 Equity Shares of face value of ^10 per
equity share at an issue price of ^126 per equity share (including a premium of ^116 per
equity share). The primary purpose of the fresh issue was to fund capital expenditure for
setting up new manufacturing line of SteriPort and SVP at Hariyala, Kheda, Gujarat, and
support general corporate purposes.
The offer also included provisions for participation by qualified
institutional buyers (QIBs), non-institutional investors (NIIs), and retail individual
investors (RIIs), in accordance with SEBI regulations. NSE has been designated as the lead
stock exchange for the issue.
Amanta Healthcare Limited made a stellar debut on the National Stock
Exchange of India Limited (NSE) and BSE Limited (BSE) on 9th September, 2025.
Following the listing, the shares of the Company are traded in electronic form under the
symbol: [NSE Trading Symbol: AMANTA & BSE Scrip Code:544502]”.
The Company is regular in payment of Annual Listing Fees. The Company
has paid Listing fees up to the year 2026-27.
3. REPORT ON THE UTILISATION OF PROCEEDS OF THE
INITIAL PUBLIC OFFER RAISED DURING THE FINANCIAL YEAR 2025-26
The Company has appointed ‘CRISIL Ratings Limited? as the
monitoring agency to monitor the utilization of the issue proceeds from the Initial Public
offer of the Company raised during the financial year 2025-26.
The Monitoring agency duly submit its report on a quarterly basis to
the Audit Committee and the Board of Directors. The Audit Committee and Board of Directors
duly took note of the same and filed it with the stock exchange as required under
Regulation 32(6) of the SEBI (Listing Obligations & Disclosure Requirements)
Regulations, 2015.
During the quarter ended September 30, 2025, net proceeds have been
revised from Rs. 10,673.57 lakhs to Rs. 10,315.19 lakhs, on account of actual issue
expenses being higher than estimated as disclosed in the Prospectus, by Rs. 358.38 lakhs
and the same has been adjusted with General corporate purposes.
4. RESERVES
Your Company does not propose to transfer any amount to general
reserve.
5. ANNUAL RETURN
In terms of Section 92(3) of the Companies Act, 2013 and Rule 12 of the
Companies (Management and Administration) Rules, 2014, the Annual Return of the Company is
available on the website of the Company and may be accessed through www.amanta.co.in.
6. DIRECTORS RESPONSIBILITY STATEMENT
In accordance with the provisions of Section 134(5) of the Companies
Act, 2013 your Directors confirm to the best of their knowledge and belief that:
a) In the preparation of the annual accounts, the applicable accounting
standards had been followed along with proper explanation relating to material departures;
b) The Directors had selected such accounting policies and applied them
consistently and made judgments and estimates that are reasonable and prudent so as to
give a true and fair view of the state of affairs of the company at the end of financial
year and of the profit and loss of the company for that period.
c) The Directors had taken proper and sufficient care for the
maintenance of adequate accounting records in accordance with the provisions of this Act
for safeguarding the assets of the company and for preventing and detecting fraud and
other irregularities;
d) The Directors had prepared the annual accounts on a going concern
basis;
e) The directors, had laid down internal financial controls to be
followed by the company and that such internal financial controls are adequate and
operating effectively; and
f) The Directors had devised proper systems to ensure compliance with
the provisions of all applicable laws and that such systems were adequate and operating
effectively.
7. DIRECTORS AND KEY MANAGERIAL PERSONNELS
Board of Directors
The composition of the Board of Directors of the Company is in
accordance with the provisions of Section 149 of the Act and Regulation 17 of the Listing
Regulations, with an appropriate combination of Executive, Non-Executive, and Independent
Directors. The Board of the Company has 6 (Six) Directors comprising of 1 (One) Managing
Director, 2 (Two) Non-Executive Directors, and 3 (Three) Independent Directors (including
a Woman Director). The complete list of Directors of the Company along with their brief
profile has been provided in the Report on Corporate Governance forming part of this
Annual Report.
Further, all the Directors and senior management personnel of the
Company affirmed compliance with the Code of Conduct for the financial year 2025-2026 and
the declaration in this respect appears elsewhere in the Annual Report.
In accordance with the provisions of Section 152 and other applicable
provisions, if any, of the Companies Act, 2013 and the Articles of Association of the
Company, Mr. Nimesh P Patel, Non-executive Director is liable to retire by rotation at the
ensuing 31st AGM and being eligible, has offered himself for re-appointment.
Company has not received any amount from a director or a relative of the director of the
Company, as deposit or otherwise, during the year under review.
Key Managerial Personnels
As on the date of this report, the following are Key Managerial
Personnels (“KMPs”) of the Company as per Sections 2(51) and 203 of the
Companies Act, 2013:
1. Shri Bhavesh Girishbhai Patel, Managing Director,
2. Shri Shailesh Shah, Chief Financial Officer (up to May 17, 2025)
2. Shri Paras Mehta, Chief Financial Officer (from May 26, 2025) and
3. Ms. Nikhita Dinodia, Company Secretary and Compliance officer
During the FY 2025-26, Shri Shailesh Shah ceased to be KMP on account
of his resignation w.e.f May 17, 2025.
Further, Shri Paras Mehta was appointed as Chief Financial Officer with
effect of 26th May, 2025.
Independent Directors
The Independent Directors had submitted their disclosures to the Board
that they fulfil the requirements as stipulated under Section 149(6) of the Act and
Regulation 25(8) of Listing Regulations. There had been no change in the circumstances
affecting their status as Independent Directors of the Company to qualify themselves to be
appointed as Independent Directors under the provisions of the Act and the relevant
regulations. The Independent Directors have given the declaration under Rule 6(3) of the
Companies (Appointment and Qualification of Directors) Rules, 2014 confirming compliance
with Rule 6(1) and (2) of the said Rules that their names are registered in the databank
as maintained by the Indian Institute of Corporate Affairs (“IICA”).
In the opinion of the Board, Mr. Kshitij Manubhai Patel, Mr. Nitin Jain
and Ms. Anjali Nirav Choksi are persons of integrity and fulfils requisite conditions as
per applicable laws and are independent of the management of the Company.
During the year under review, the Independent Directors of the Company
had no pecuniary relationship or transactions with the Company, other than sitting fees,
and reimbursement of expenses, if any.
Shri Nitin Jain, Independent Director, holds 1 equity shares of the
Company, Smt. Dympal Jain, wife of Shri Nitin Jain (Independent Director) holds 15,676
equity shares of the Company, and Ms. Anjali Nirav Choksi, Independent Director, holds
1500 equity shares of the Company during the financial year ended 31st March,
2026.
The Board is of the view that Mr. Kshitij Manubhai Patel, Mr. Nitin
Jain and Ms. Anjali Nirav Choksi possess adequate integrity, expertise (including the
proficiency) and experience for the effective and efficient discharge of duties of
Independent Directors.
Separate meeting of Independent Directors
During the year under review, a separate meeting of Independent
Directors of the Company was held on 22nd August, 2025 and 16th
March, 2026 to consider:
I. Recommendation of the price band in relation to the public offer;
II. the Performance evaluation of Chairperson, Non-Independent
Directors and the Board as a whole; and
III. assess the quality, quantity and timeliness of flow of information
between the Company?s Management and the Board that is necessary for the Board to
effectively and reasonably perform their duties.
Committees of the Board
During the year 2025-26, in compliance with the SEBI listing
regulations, the Company has constituted mandatory committees as mentioned below.
Audit Committee
| Sr. No. Name of the
Chairperson/Member |
Position in the Committee |
| 1. Mr. Kshitij Manubhai Patel |
Chairperson |
| 2. Mr. Bhavesh Girishbhai Patel* |
Member |
| 3. Ms. Anjali Nirav Choksi |
Member |
*Mr. Nimesh P Patel ceases to be member of Audit Committee w.e.f.
11.11.2025 due to his other pre-occupancies.
*Mr. Bhavesh Girishbhai Patel has been appointed as member of Audit
Committee w.e.f. 11.11.2025.
Nomination and Remuneration Committee
| Sr. No. Name of the
Chairperson/Member |
Position in the Committee |
| 1. Mr. Kshitij Manubhai Patel |
Chairperson |
| 2. Mr. Nimesh P Patel |
Member |
| 3. Ms. Anjali Nirav Choksi |
Member |
Corporate Social Responsibility Committee
| Sr. No. Name of the
Chairperson/Member |
Position in the Committee |
| 1. Mr. Bhavesh Girishbhai Patel |
Chairperson |
| 2. Mr. Kshitij Manubhai Patel |
Member |
| 3. Mr. Nimesh P Patel |
Member |
| 4. Ms. Anjali Nirav Choksi |
Member |
Stakeholders Relationship Committee
| Sr. No. Name of the
Chairperson/Member |
Position in the Committee |
| 1. Mr. Nimesh P Patel |
Chairperson |
| 2. Mr. Kshitij Manubhai Patel |
Member |
| 3. Ms. Anjali Nirav Choksi |
Member |
Initial Public Offer Committee (IPO Committee)*
| Sr. No. Name of the
Chairperson/Member |
Position in the Committee |
| 1. Mr. Bhavesh Girishbhai Patel |
Chairperson |
| 2. Mr. Kshitij Manubhai Patel |
Member |
| 3. Mr. Nimesh P Patel |
Member |
*IPO Committee dissolved with effect of 5th August, 2026.
Familiarization Program for Independent Directors
Board understand the value of familiarization for the independent
directors, thus the Independent directors are being acquainted at the time of their
joining Company?s business, industry?s overview, its business model, and other
associated elements. On regular basis they are being acquainted with company?s
performance, business updates, associated risks and opportunities etc. through various
presentations at the meeting of the board of directors of the Company and that the
regulatory updates are also presented or circulated to the Board members from time to time
towards their familiarization program.
8. BOARD MEETING
The details of composition of the Board, its committees, their meetings
held and attendance of the Directors at such meetings are provided in the Corporate
Governance Report, which is a part of this Report.
Following is the meeting of Board of Directors during the Financial
Year 2025-26.
| Sr. No. |
Date of Board Meeting |
No. of Directors attended the meeting
out of total strength of 6 Directors |
Whether Quorum was present |
| 1 |
17-05-2025 |
5 |
Yes |
| 2 |
17-07-2025 |
6 |
Yes |
| 3 |
25-07-2025 |
5 |
Yes |
| 4 |
22-08-2025 |
5 |
Yes |
| 5 |
29-08-2025 |
2 |
Yes |
| 6 |
04-09-2025 |
5 |
Yes |
| 7 |
26-09-2025 |
5 |
Yes |
| 8 |
11-11-2025 |
5 |
Yes |
| 9 |
19-01-2026 |
6 |
Yes |
| 10 |
10-02-2026 |
6 |
Yes |
| 11 |
26-03-2026 |
6 |
Yes |
9. PERFORMANCE EVALUATION OF THE BOARD, BOARD
COMMITTEES, AND DIRECTORS
The Company has adopted the Board Evaluation Framework and Policy based
on the recommendation of the Nomination and Remuneration Committee (NRC), which sets a
mechanism and criteria for performance evaluation of the Board, Board Committees and
Directors, including Independent Directors. The same is available at the website of the
Company www.amanta.co.in.
The performance of the Board, the Committees and individual Directors
was evaluated by the Board after seeking inputs from all the Directors through a
questionnaire wherein the Directors evaluated the performance on scale of one to ten based
on the following criteria:
a) Criteria for Board performance evaluation includes degree of
fulfilment of key responsibilities, Board structure and composition, establishment, and
delineation of responsibilities to committees, effectiveness of board processes,
information and functioning, board culture and dynamics, quality of relationship between
the Board and the management.
b) Criteria for Committee performance evaluation includes degree of
fulfilment of key responsibilities, adequacy of committee composition, effectiveness of
meetings, committee dynamics, quality of relationship of the committee with the Board, and
the management.
c) Criteria for performance evaluation of Individual Directors includes
fulfilment of the independence criteria as specified in the Listing Regulations and their
independence from the management, attendance, contribution at meetings, guidance, support
to management outside Board/ Committee meetings.
The above criteria are broadly based on the Guidance Note on Board
Evaluation issued by the Securities and Exchange Board of India on January 5, 2017.
The NRC also reviewed the performance of the individual directors. In a
separate meeting of Independent Directors, performance of Non-Independent Directors and
performance of the Board was evaluated, views of the Non-Executive Directors were also
taken.
The Board and the NRC reviewed the performance of individual Directors
on the basis of criteria such as the contribution of the individual Directors to the Board
and Committee meetings like preparedness on the issues to be discussed, meaningful and
constructive contribution and inputs in meetings, etc.
In the Board meeting that followed the meeting of the Independent
Directors and meeting of NRC, the performance of the Board, its committees and individual
directors were also discussed.
Performance evaluation of Independent Directors was done by the entire
Board, excluding the Independent Director being evaluated.
10. NET WORTH OF THE COMPANY
The Net Worth of the Company as on 31st March 2026 is Rs.
22021.10 Lakhs as compared to Rs. 9638.83 Lakhs as on 31st March, 2025.
11. PARTICULARS OF LOANS, GUARANTEES OR
INVESTMENTS
As at 31st March, 2026, the Company has no intercorporate
loans, guarantees, investments or security as specified in Section 186 of the Act.
12. RELATED PARTY TRANSACTIONS
The Company has a Policy on Materiality of Related Party Transactions
and on dealing with Related Party Transactions, in accordance with the Companies Act, 2013
and the Securities and Exchange Board of India (Listing Obligations and Disclosure
Requirements) Regulations, 2015. This Policy is disclosed on the website of the company
and may be accessed through www.amanta.co.in.
During the financial year under consideration, all contracts /
transactions entered into by the Company with related parties were in the ordinary course
of business and on arm?s length basis. The Company has not entered into any contract
/ arrangement / transaction with related party(ies) which may be termed as material in
nature and not executed in ordinary course of business and not on arm?s length basis.
Hence, details are not required to be furnished in Form AOC-2 as “Annexure-1”.
13. DIVIDEND AND DIVIDEND DISTRIBUTION POLICY
The Board of Directors of the Company (“Board”), after
considering the relevant circumstances holistically and keeping in view the Company?s
Dividend Distribution Policy, has decided that it would be prudent not to recommend any
dividend for the year under review.
In compliance with Regulation 43A of the Securities and Exchange Board
of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, the Company
has Dividend Distribution Policy in place. This policy is disclosed on the website of the
Company and may be accessed through www.amanta.co.in.
14. TRANSFER OF UNCLAIMED DIVIDEND TO INVESTOR EDUCATION AND PROTECTION
FUND
There were no amounts which were required to be transferred to the
Investor Education and Protection Fund by the Company during the year ended March 31,
2026.
15. MATERIAL ORDER PASSED BY REGULATORS
No significant or material orders were passed by the Regulators or
Courts or Tribunals which impact the going concern status and Company?s operations in
future.
16. THE DETAILS OF APPLICATION MADE OR ANY PROCEEDING PENDING UNDER THE
INSOLVENCY AND BANKRUPTCY CODE, 2016
Neither application was made nor any proceeding is pending under the
Insolvency and Bankruptcy Code, 2016.
17. MATERIAL CHANGES AND COMMITMENTS, AFFECTING THE FINANCIAL POSITION
OF THE COMPANY
No material changes and commitments affecting the financial position of
the Company occurred between the end of the financial year to which these financial
statements relate and the date of this Report.
18. THE DETAILS OF DIFFERENCE BETWEEN AMOUNT OF THE VALUATION DONE AT
THE TIME OF ONE TIME SETTLEMENT AND THE VALUATION DONE WHILE TAKING LOAN FROM THE BANKS OR
FINANCIAL INSTITUTIONS ALONG WITH THE REASONS THEREOF
No settlements have been done with banks or financial institutions.
19. CONSERVATION OF ENERGY AND TECHNOLOGY ABSORPTION AND FOREIGN
EXCHANGE EARNINGS AND OUTGO
The information pertaining to conservation of energy, technology
absorption, foreign exchange Earnings and outgo as required under Section 134(3)(m) of the
Companies Act, 2013 read with Rule 8(3) of the Companies (Accounts) Rules, 2014 forms part
of this report and is given by way of “Annexure- 2”.
20. RISK MANAGEMENT
The Company has put in place a Risk Management Policy to define a
framework for identification, assessment, categorization and treatment of risks and
selecting appropriate risk management approach. The Company?s outlook in dealing with
various risks associated with the business includes the decision on acceptance of risks,
avoidance of risks, transfer of risks and risks tolerance level.
This Policy is disclosed on the website of the company and may be
accessed through www.amanta.co.in.
21. INTERNAL CONTROL SYSTEM AND ITS ADEQUACY
The Company has effective internal control system in place, which
ensures that all the assets of the Company are safeguarded and protected against any loss
from unauthorized use or disposition. The Company has also put in place adequate internal
controls with reference to the financial statements commensurate with the size and nature
of operations of the Company. Such controls were tested and test results summary of the
testing done based on key controls shown effective controls prevailing within the Company
during the year under review.
Internal auditor of the Company also periodically carry out review of
the internal control system and procedures and their reports are placed before Audit
Committee for review. There were no significant comments / findings in the reports of
Internal auditor during the year under review.
22. CORPORATE SOCIAL RESPONSIBILITY COMMITTEE
In compliance with the requirements of Section 135 of the Companies
Act, 2013 (‘the Act?) read with the Companies (Corporate Social Responsibility
Policy) Rules, 2014 (CSR Rules), the Board of Directors have constituted a Corporate
Social Responsibility Committee. Annual Report on CSR containing particulars specified in
Annexure II to the CSR Rules is forming part of the Board?s Report as per “Annexure
3”.
The contents of the CSR Policy of the Company as approved by the Board
on the recommendation of the Corporate Social Responsibility Committee and other details
are available on the website of the Company and may be accessed through www.amanta.co.in.
23. POLICY ON DIRECTOR?S APPOINTMENT AND REMUNERATION
Nomination Policy acts as a guideline for determining qualifications,
positive attributes, independence of Directors and matters related to the appointment and
removal of Directors and Senior Management.
Remuneration Policy lays down the Company?s philosophy and
criteria as well as manner of determining the remuneration of Managing Director,
Executive/
Non-Executive Directors, Independent Directors, Senior Management, Key
Managerial Personnel and other employees.
The Board has, on the recommendation of the Nomination and Remuneration
Committee, approved a policy for selection and appointment of Directors, Key Managerial
Personnel, Senior Management and for determining their remuneration. The Policy of the
Company on directors? appointment and remuneration, including the criteria for
determining qualifications, positive attributes, independence of a director and other
matters, as required under sub-section (3) of Section 178 of the Companies Act, 2013, is
available on Company?s website and accessible through www.amanta.co.in.
24. VIGIL MECHANISM/WHISTLE BLOWER POLICY
The Company has in place Vigil Mechanism/ Whistle Blower Policy. It
lays down a mechanism for reporting and investigation of all unethical behaviour, alleged
or potential violations of laws, regulations or Code of Conduct, policies, procedures or
other standards.
Employees have numerous ways to voice their concerns and are encouraged
to report the same internally for resolution. The said Policy provides for adequate
safeguards against retaliation and access to the Chairperson of the Audit Committee.
The Whistle Blower Policy is available on Company?s website and
accessible through www.amanta.co.in.
25. CODE FOR PREVENTION OF INSIDER TRADING
Company has adopted a Code of Conduct (“Code”) to regulate,
monitor and report trading in Company?s shares by Company?s designated persons
and their immediate relatives as per the requirements under the Securities and Exchange
Board of India (Prohibition of Insider Trading) Regulations, 2015.
The Code, inter alia, lays down the procedures to be followed by
designated persons while trading/ dealing in Company?s shares and sharing Unpublished
Price Sensitive Information (“UPSI”). The Code covers the Company?s
obligation to maintain a digital database, mechanism for prevention of insider trading and
handling of UPSI, and the process to familiarize with the sensitivity of UPSI. Further, it
also includes code for practices and procedures for fair disclosure of unpublished price
sensitive information which has been made available on the Company?s website www.amanta.co.in.
26. CREDIT RATING
During the year CRISIL Ratings Limited has improved credit rating of
the Company from BBB- to BBB, based on improved Financials and Business operations of the
Company. Accordingly, current Ratings are as under:
| Facilities |
Ratings Agency |
Rating |
Dated |
| Long term Bank Facilities |
CRISIL Ratings Limited |
CRISIL BBB/stable |
February 16, 2026 |
| Short Term Bank Facilities |
CRISIL Ratings Limited |
CRISIL A3+ |
February 16, 2026 |
27. SUBSIDIARIES, JOINT VENTURES AND ASSOCIATE COMPANIES
The Company does not have any Subsidiary, Joint venture or Associate
Company.
Company have also framed a policy for determining “material”
subsidiaries and the same is available on Company?s website and accessible through www.amanta.co.in.
28. DEPOSITS
The Company has neither accepted nor renewed any deposits during the
year. The Company does not have any deposits outstanding as at 31st March,
2026.
29. INSURANCE
The Company?s properties including building, plant and machinery,
stocks, stores, etc. continue to be adequately insured against risks such as fire, riot,
strike, civil commotion, malicious damages, earthquake, flood, etc.
30. AUDITORS
Statutory Auditor
M/s Price Waterhouse Chartered Accountants LLP, with Firm Registration
Number 012754N/N500016, have been re-appointed as Statutory Auditor of the Company to hold
office for a further period of 5 Years commencing from the conclusion of 27th Annual
General Meeting until the conclusion of the 32nd Annual General Meeting of the
Company. The observations of the Auditors in their report on Accounts and the Financial
Statements, read with the relevant notes are self-explanatory. The Audit Report does not
contain any qualification, reservation, adverse remark, or disclaimer.
Further, Statutory Auditor have confirmed their eligibility under
Section 141 of the Companies Act, 2013 and the Rules framed there under.
Cost Auditor
As per the requirements of the Section 148 of the Act read with the
Companies (Cost Records and Audit) Rules, 2014 as amended from time to time, the Company
is required to maintain cost records and accordingly, such accounts are made and records
have been maintained every year.
The Board has appointed, M/s. Y.S. Thakar & Co. (FRN: 000318), Cost
Accountants, as the Cost Auditor to conduct the audit of the Cost Records of the Company
for the Financial Year ended March 31, 2026.
Pursuant to Section 148 of the Companies Act, 2013 read with The
Companies (Cost Records and Audit) Amendment Rules, 2014, the Directors on the
recommendation of the Audit Committee, re-appointed M/s Y.S. Thakar & Co., Cost
Accountants, to audit the Cost Accounts of the Company for the Financial Year ending March
31, 2027 on a remuneration of Rs. 75,000 plus GST & out of pocket expenses.
As required under the Companies Act, 2013, the remuneration payable to
the Cost Auditor is required to be placed before the Members in a general meeting for
their ratification. Accordingly, a resolution seeking Member?s ratification for the
remuneration payable to M/s. Y.S. Thakar & Co., Cost Accountants for the Financial
Year ending March 31, 2027, is proposed in the Notice convening the Annual General
Meeting.
Cost Audit Report
As per the provisions of Section 148(1) of the Companies Act, 2013, the
Company has maintained the cost records, as specified by the Central Government. The Cost
Audit Report for the financial year does not contain any quaLification(s), reservation(s)
or adverse remark(s) or disclaimer.
Internal Auditor
M/s. Parikh Shah & Associates, Chartered Accountants, (Firm
Registration No. 123999W) are the Internal Auditors of the Company for the financial year
202627. Further, M/s. Parikh Shah & Associates, Chartered Accountants are reappointed
as Internal Auditors of the Company for the financial year 2026-27.
Internal Audit Report, their significant observations and follow up
actions taken by the Management is reviewed by the Audit Committee.
Secretarial Auditor
The Secretarial Audit Report for the financial year ended March 31,
2026, is annexed as “Annexure-4” and forms an integral part of this
Annual Report.
During the period under review, the Company has complied with the
provisions of the Act, Rules, Regulations, Guidelines, Standards etc. covered under the
Secretarial Audit. The Secretarial Audit Report does not contain any qualification,
reservation, or adverse remark.
The Board has appointed M/s Kashyap R. Mehta & Partners, a firm of
Practising Company Secretaries to conduct Secretarial Audit of the Company for a period of
5 year from the financial year 2026-27 till the FY 2030-31 subject to approval of
members/sharehoLders pursuant to Regulation 24A of SEBI (Listing Obligations and
Disclosure Requirements) Regulations, 2015.
Auditor?s Report and Secretarial Audit Report
The observations of the Auditors in their report on Accounts and the
Financial Statements, read with the relevant notes are self-explanatory. The Audit Report
does not contain any qualification, reservation, adverse remark, or disclaimer.
In terms of Section 204 of the Companies Act, 2013 and Regulation 24A
of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, a
Secretarial Audit Report given by the Secretarial Auditors in Form No. MR-3 is annexed
with this Report. There are no qualifications, reservations or adverse remarks made by
Secretarial Auditors in their Report.
31. FRAUDS REPORTED BY THE AUDITORS
There was no instance of fraud during the year under review, which
required the Statutory Auditors to report to the Audit Committee and / or to the Board as
required under Section 143(12) of the Act and the rules made thereunder.
32. REPORT ON CORPORATE GOVERNANCE
The Company is committed to adhere to the Corporate Governance
requirements as stipulated under the Companies Act, 2013 read with the rules and
regulations issued by the Securities and Exchange Board of India. Report on Corporate
Governance for the financial year under review, and a certificate regarding compliance
with the conditions of Corporate Governance are appended to the Annual Report as “Annexure
- 5”.
33. PREVENTION OF SEXUAL HARRASMENT AT WORKPLACE
As per the requirement of The Sexual Harassment of Women at Workplace
(Prevention, Prohibition & Redressal) Act, 2013 and rules made thereunder, the Company
has laid down a Prevention of Sexual Harassment (POSH) Policy and has constituted Internal
Committees (ICs), to consider and resolve the complaints related to sexual harassment. The
ICs includes external members with relevant experience and a senior women as presiding
officer. Company has zero tolerance on sexual harassment at the workplace. The ICs also
work extensively on creating awareness on relevance of sexual harassment issues. The
employees are required to undergo a mandatory training/ certification on POSH to sensitize
themselves and strengthen their awareness.
ALL new employees go through a detailed personal orientation on
anti-sexual harassment policy adopted by the Company.
| Sr. No |
Number of Complaints of Sexual
Harassment received in the year; |
Number of Complaints disposed off during
the year; |
Number of cases pending for more than 90
days |
| 1. |
0 |
0 |
0 |
34. STATEMENT BY THE COMPANY WITH RESPECT TO THE COMPLIANCE TO THE
PROVISIONS RELATING TO THE MATERNITY BENEFITS ACT, 1961
This is to certify that Amanta Healthcare Limited is fully compliant
with the provisions of the Maternity Benefit Act, 1961, as amended from time to time.
The Company ensures the following in accordance with the Act:
Maternity Leave: Female employees are granted maternity leave of 26
weeks (for the first two children) with full wages, as per Section 5 of the Act. For
subsequent children, 84 days of maternity leave is provided.
Payment of Maternity Benefit: Eligible women employees are paid
maternity benefit at the rate of the average daily wage for the period of their actual
absence from duty.
Medical Bonus: An amount of '3500/- will be paid one time
“Medical Bonus” once employee resumes duty.
Prohibition of Dismissal: No woman employee is dismissed or
discharged on account of her absence due to maternity leave, and all benefits are
preserved during such leave.
Awareness and Support: The Company actively informs and supports
its female employees about their rights and entitlements under the Act.
Your Company is committed to safeguarding the rights of its female
employees and maintaining a workplace that is compliant with all applicable labour laws.
35. DISCLOSURE UNDER SECTION 197(12) OF THE COMPANIES ACT, 2013 AND
OTHER DISCLOSURES AS PER RULE 5 OF THE COMPANIES (APPOINTMENT AND REMUNERATION OF
MANAGERIAL PERSONNEL) RULES, 2014
Disclosures required in accordance with the provisions of Section
197(12) of the Act, read with Rule 5(1) of the Companies (Appointment and Remuneration of
Managerial Personnel) Rules, 2014, forms part of this Report. However, as per the
provisions of Sections 134 and 136 of the Companies Act, 2013, the Report and Financial
Statements are being sent to the Members and others entitled thereto, excluding the
Statement containing Particulars of Employees, which is available for inspection by the
Members up to the date of ensuing Annual General Meeting. Any Member interested in
obtaining a copy of such Statement may write to the Company Secretary at cs@amanta.co.in.
(a) The percentage increase in remuneration of each Director, Chief
Financial Officer and Company Secretary of the Company and (b) ratio of the remuneration
of each director to the median remuneration of the employees of the Company for the
financial year 2025-26:
| Name of Director/KMPs |
% increase in remuneration |
Ratio of remuneration of each director/
to the median remuneration of employees |
| Bhavesh Girishbhai PateL (Chairman and
Managing Director) |
0% |
24.90:1 |
| Paras Mehta (Chief Financial Officer) |
N. A. |
N.A. |
| Nikhita Dinodia (Company Secretary and
Compliance Officer) |
35% |
1.69:1 |
c) The percentage increase in the median remuneration of employees in
the financial year: 11.70%.
d) Number of permanent employees on the rolls of the Company: 460
Employees.
e) Average percentage increase made in the salaries of employees
(including workmen) other than the managerial personnel in the financial year was 12.2%,
whereas the increase in the managerial remuneration was 35%. The average increases every
year is an outcome of the Company?s market competitiveness and business performance.
Keeping in mind our Nomination and Remuneration policy and benchmarking results, the
increases this year reflect market practice.
f) It is hereby affirmed that the remuneration paid to Directors, Key
Managerial Personnels and other Employees is as per the Remuneration Policy of the
Company.
PARTICULARS OF EMPLOYEES:
There is no Employee drawing remuneration requiring disclosure under
Rule 5(2) of Companies (Appointment & Remuneration of Managerial personnel) Rules,
2014.
36. ENVIRONMENT, HEALTH AND SAFETY
The Company is committed to health and safety of its employees,
contractors and visitors. We are pleased to say that we are compliant of Environmental,
Health & Safety (EHS) Regulations stipulated under the Water (Prevention and Control
of Pollution) Act, The Air (Prevention and Control of Pollution) Act, The Environment
Protection Act and other applicable Industrial Laws. Our mandate is not to comply but to
go beyond compliance standards, and we are progressive in this direction. The health and
safety of our people is paramount. We prepare our people as much as possible for the
potential risks in our facilities. This preparation includes adherence to clear standards,
education, training, auditing and follow-up to reinforce accountability.
37. DEMATERIALIZATION OF EQUITY SHARES
Shareholders have an option to dematerialise their shares with either
of the depositories viz NSDL and CDSL. The ISIN No. allotted is INE084k01015.
38. SECRETARIAL STANDARDS
The Company has complied with the applicable provisions of Secretarial
Standards 1 and 2 issued by the Institute of Company Secretaries of India and notified by
the Ministry of Corporate Affairs.
39. OTHER DISCLOSURES
The Directors state that no disclosure or reporting is required in
respect of the following items, as there were no transactions/events of these nature
during the year under review:
• Significant or material orders passed by the Regulators or
Courts or Tribunals which impact the going concern status and the Company?s operation
in future;
• Issue of equity shares with differential rights as to dividend,
voting or otherwise;
• Issue of sweat equity shares to directors or employees;
• Issue of bonus shares or ESOPs to employees of the Company;
• One time settlement of loan obtained from the Banks or Financial
Institutions.
40. CAUTIONARY STATEMENT
Statements in the Annual Report, including those which relate to
Management Discussion and Analysis describing the Company?s objectives, projections,
estimates and expectations, may constitute ‘forward looking statements? within
the meaning of applicable laws and regulations. Although the expectations are based on
reasonable assumptions, the actual results might differ.
41. ACKNOWLEDGEMENTS
The Directors are highly grateful for all the guidance, support and
assistance received from the Government of India, Governments of various states in India,
concerned Government departments, Financial Institutions and Banks. The Directors thank
all the esteemed shareholders, customers, suppliers and business associates for their
faith, trust and confidence reposed in the Company
The Directors wish to place on record their sincere appreciation for
the dedicated efforts and consistent contribution made by the employees at all levels, to
ensure that the Company continues to grow and excel.
|
For and on behalf of the Board |
|
Bhavesh Girishbhai Patel |
| Place: Ahmedabad, Gujarat |
Chairman & Managing Director |
| Date: 5th August, 2026 |
DIN: 00085505 |
